Skip to content

Determining the 90% Effective Dose of Oliceridine for Inhibiting Endotracheal Intubation and Laryngeal Mask Airway Insertion Responses : A Biased-Coin Sequential Dose-Finding Trial

Determining the 90% Effective Dose of Oliceridine for Inhibiting Endotracheal Intubation and Laryngeal Mask Airway Insertion Responses: A Biased-Coin Sequential Dose-Finding Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095893
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial airway insertion reaction

Interventions

group A (Young and middle-aged laryngeal mask group):Oliceridine
group B (Elderly laryngeal mask group):Oliceridine
Group C ( young and middle-aged tracheal intubation group ):Oliceridine
Group D ( elderly tracheal intubation group ):Oliceridine

Sponsors

Changshu Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1 patients undergoing elective surgery under general anesthesia ; 2 Age 18-85 years old ; 3 American Society of Anesthesiologists ( ASA ) grade I-III ; 4 body mass index ( BMI ) : 18-30 kg / m^2.

Exclusion criteria

Exclusion criteria: 1 Patients with long-term use of sedative and analgesic drugs, drug or alcohol abuse history ; 2 patients with mental illness or mental retardation, hearing impairment ; 3 patients with uncontrolled hypertension, glaucoma, hyperthyroidism and pheochromocytoma ; 4 patients with severe dysfunction of heart, lung, kidney and liver ; 5 patients with pathological obesity, myasthenia gravis, severe depression, epilepsy, psychiatric history .

Design outcomes

Primary

MeasureTime frame
The 90% effective dose;

Secondary

MeasureTime frame
Systolic blood pressure;BIS;Vascular active drug usage;Diastolic blood pressure;Mean arterial pressure;heart rate;

Countries

China

Contacts

Public ContactXu Fangsheng

Affiliated Changshu Hospital of Nantong University

x1255125543@gmail.com+86 188 9536 2110

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026